Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular DystrophyJonathan Oliva(University of Washington), Francis M. Sverdrup(University of Washington)Journal of Pharmacology and Experimental TherapeuticsJune 13, 201910.1124/jpet.119.259663Cited by 89SaveCiteExport RISWatch citationsRelated PapersSIX transcription factors are necessary for the activation of DUX4 expression in facioscapulohumeral muscular dystrophy|Skeletal Muscle|2024|7